Skip to main content

Effect of Intra-arterial and Intravenous Application of Prostaglandin E1 on Neutrophil Function in Peripheral Arterial Occlusive Disease

  • Conference paper
Prostaglandin E1
  • 47 Accesses

Abstract

In peripheral arterial occlusive disease systemic changes in neutrophil function suggestive of cell activation have been found [10]. Furthermore, it has been shown that intermittent claudication causes additional local alterations of neutrophil function [12]. Recent experimental results suggest that neutrophil activation may promote interactions between leucocytes, platelets, and endothelial cells [2, 3, 5, 6, 8]. These cell-cell interactions appear to involve an ongoing release of predominantly leucocyte-derived toxic compounds [15], resulting in progressive microvascular injury during ischaemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. DeChalet LR, Shirley PS (1981) Evaluation of chronic granulomatous disease by a chemiluminescence assay of microliter quantities of whole blood. Clin Chem 27: 1739–1741

    Google Scholar 

  2. Engler RL, Dahlgren MD, Morris DD, Peterson MA, Schmid-Schonbein GW (1986) Role of leucocytes in the response to acute myocardial ischemia and reperfusion in the dog. Am J Physiol 251: H314–322

    PubMed  CAS  Google Scholar 

  3. Goldstein IM, Roos A, Kaplan HB, Weissmann G (1975) Complement and immunoglobulins stimulate superoxide anion production independent of phagocytosis. J Clin Invest 56: 1155–1157

    Article  PubMed  CAS  Google Scholar 

  4. Golub M, Zia P, Matsuno M, Horton R (1975) Metabolism of prostaglandins A1and E1 in man. J Clin Invest 56: 1404–1406

    Article  PubMed  CAS  Google Scholar 

  5. Gruber HE, Hoffer ME, McAllister DR, Laikind PK, Lane TA, Schmid-Schönbein GW, Engler RL (1989) Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury. Circulation 80: 1400–1411

    Article  PubMed  CAS  Google Scholar 

  6. Harlan JM (1985) Leukocyte-endothelial interactions. Blood 65: 513–525

    PubMed  CAS  Google Scholar 

  7. Hecker G, König E, Ney P, Schrör K (1987) Potent inhibition of PAF-stimulated human platelets and polymorphonuclear leucocytes by the PGE1 analog OP-1206. In: Sinzinger H, Schrör K (eds) Prostaglandins in clinical research. Liss, New York, pp 317–322

    Google Scholar 

  8. Mehta JL, Nichols WW, Mehta P (1988) Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. J Am Coll Cardiol 11: 1306–1316

    Google Scholar 

  9. Nash GB, Jones JG, Mikita J, Dormandy J A (1988) Methods and theory for analysis of flow of white cell subpopulations through micropore filters. Br J Haematol 70: 165–170

    Article  PubMed  CAS  Google Scholar 

  10. Nash GB, Thomas PRS, Dormandy JA (1988) Abnormal flow properties of white blood-cells in patients with severe ischemia of the leg. Br Med J 296: 1699–1701

    Article  CAS  Google Scholar 

  11. Neumann FJ, Diehm C, Müller-Bühl U, Weiss T, Zimmermann R, Tillmanns H, Kübler W (1989) Einfluß von Prostaglandin E1 auf Funktion und Verformbarkeit neutrophiler Granulozyten bei Patienten mit peripherer arterieller Verschlußkrankheit im Stadium IV. Vasa Suppl 27: 40–41

    PubMed  CAS  Google Scholar 

  12. Neumann FJ, Waas W, Diehm C, Weiss T, Haupt H, Zimmermann R, Tillmanns H, Kübler W (1990) Activation and decreased deformability of neutrophils after intermittent claudication. Circulation 82: 1122–1129

    Article  Google Scholar 

  13. Park BH, Fikrig SM, Smithwick EM (1968) Infection and nitroblue-tetrazolium reduction by neutrophils: a diagnostic aid. Lancet ii: 532–534

    Google Scholar 

  14. Peskar BA, Hesse WH, Rogatti W, Diehm C, Rudofsky G, Schweer H, Seyberth HW (1991) Formation of 13,14-dihydro-prostaglandin E1 during intravenous infusions of prostaglandin E1 in patients with peripheral arterial occlusive disease. Prostaglandins 41: 225–228

    Article  PubMed  CAS  Google Scholar 

  15. Schrör K, Hecker G (1986) Different effects of E- and I-type prostaglandins on human platelet and polymorphonuclear cell function. In: Sinzinger H, Rogatti W (eds) Prostaglandin E1 in atherosclerosis. Springer, Berlin Heidelberg New York, pp 22–26

    Google Scholar 

  16. Simmet T, Peskar BA (1988) Prostaglandin E1 and arterial occlusive disease. Eur J Clin Invest 18: 549–552

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Neumann, FJ. et al. (1991). Effect of Intra-arterial and Intravenous Application of Prostaglandin E1 on Neutrophil Function in Peripheral Arterial Occlusive Disease. In: Diehm, C., Sinzinger, H., Rogatti, W. (eds) Prostaglandin E1 . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76910-8_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76910-8_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-54524-8

  • Online ISBN: 978-3-642-76910-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics